Diffusion Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-11.91 Insider Own0.10% Shs Outstand2.04M Perf Week3.72%
Market Cap15.93M Forward P/E- EPS next Y-7.33 Insider Trans0.00% Shs Float2.04M Perf Month1.69%
Income-24.00M PEG- EPS next Q-2.04 Inst Own8.80% Short Float4.08% Perf Quarter-38.84%
Sales- P/S- EPS this Y17.70% Inst Trans-7.23% Short Ratio0.97 Perf Half Y-61.07%
Book/sh15.02 P/B0.52 EPS next Y11.80% ROA-58.10% Target Price40.00 Perf Year-77.43%
Cash/sh15.98 P/C0.49 EPS next 5Y- ROE-62.40% 52W Range5.10 - 42.76 Perf YTD-48.79%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-82.39% Beta1.46
Dividend %- Quick Ratio11.40 Sales past 5Y- Gross Margin- 52W Low47.65% ATR1.02
Employees16 Current Ratio11.40 Sales Q/Q- Oper. Margin- RSI (14)45.22 Volatility8.62% 12.73%
OptionableNo Debt/Eq0.00 EPS Q/Q20.20% Profit Margin- Rel Volume0.04 Prev Close7.81
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume85.67K Price7.53
Recom3.00 SMA206.42% SMA50-24.78% SMA200-57.01% Volume211 Change-3.59%
Nov-17-20Downgrade H.C. Wainwright Buy → Neutral
Mar-21-18Initiated H.C. Wainwright Buy $1.25
May-20-22 08:10AM  
May-18-22 07:30AM  
May-17-22 07:30AM  
May-12-22 04:05PM  
May-04-22 07:20AM  
Apr-18-22 10:42AM  
Apr-11-22 07:20AM  
Apr-08-22 07:20AM  
Apr-06-22 10:15AM  
Mar-23-22 10:20AM  
Mar-21-22 07:20AM  
Mar-09-22 04:56AM  
Feb-24-22 07:02AM  
Dec-20-21 07:02AM  
Dec-16-21 08:59AM  
Dec-01-21 07:02AM  
Nov-30-21 11:57AM  
Nov-29-21 06:27AM  
Nov-22-21 07:02AM  
Nov-10-21 07:02AM  
Oct-28-21 07:30AM  
Sep-10-21 07:02AM  
Sep-09-21 07:32AM  
Sep-08-21 07:32AM  
Aug-30-21 07:32AM  
Aug-19-21 06:05AM  
Aug-11-21 07:32AM  
Aug-06-21 10:20AM  
Jul-06-21 06:34AM  
Jun-30-21 11:14AM  
Jun-28-21 08:35AM  
Jun-21-21 08:35AM  
Jun-18-21 07:35AM  
Jun-13-21 06:13PM  
May-14-21 08:21AM  
May-10-21 10:23AM  
Mar-25-21 11:47AM  
Mar-18-21 07:05AM  
Mar-17-21 07:05AM  
Mar-14-21 04:47AM  
Mar-04-21 04:05PM  
Feb-18-21 04:05PM  
Feb-17-21 04:13PM  
Feb-16-21 09:18AM  
Feb-11-21 10:02PM  
Jan-11-21 07:30AM  
Dec-04-20 07:20AM  
Nov-29-20 07:29PM  
Nov-18-20 11:55AM  
Nov-12-20 04:02PM  
Oct-19-20 08:00AM  
Sep-24-20 08:00AM  
Sep-17-20 03:40PM  
Sep-15-20 07:12AM  
Sep-11-20 08:30AM  
Sep-10-20 08:00AM  
Sep-08-20 04:02PM  
Sep-01-20 04:02PM  
Aug-24-20 08:32AM  
Aug-10-20 08:00AM  
Jul-27-20 08:00AM  
Jul-07-20 08:00AM  
Jul-06-20 07:47PM  
Jun-11-20 08:00AM  
Jun-01-20 08:00AM  
May-26-20 08:00AM  
May-20-20 01:00PM  
May-19-20 03:18PM  
May-18-20 09:05AM  
May-11-20 04:11PM  
May-05-20 08:00AM  
Apr-27-20 08:00AM  
Apr-03-20 07:30AM  
Apr-01-20 08:00AM  
Mar-24-20 04:05PM  
Mar-19-20 07:28AM  
Mar-18-20 06:35PM  
Mar-17-20 04:10PM  
Mar-12-20 08:00AM  
Feb-07-20 08:30AM  
Jan-10-20 08:00AM  
Dec-30-19 08:00AM  
Dec-22-19 06:43PM  
Dec-13-19 02:07PM  
Dec-12-19 09:55AM  
Dec-11-19 07:21AM  
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.